EP3565580

CONTINUOUS ADMINISTRATION OF EXENATIDE AND CO-ADMINSTRATION OF ACETAMINOPHEN, ETHINYLESTRADIOL OR LEVONORGESTREL

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    3.1.2018
  • EP published:
    6.3.2024
  • EP application number:
    18709116.0
  • Max expiry date:
    2.1.2038
  • Title in English:
    CONTINUOUS ADMINISTRATION OF EXENATIDE AND CO-ADMINSTRATION OF ACETAMINOPHEN, ETHINYLESTRADIOL OR LEVONORGESTREL
  • Language of the patent:
    English

Timeline

Today
3.1.2018EP application
6.3.2024EP Publication

Owner

  • Name:
    i2o Therapeutics, Inc.
  • Address:
    700 Main Street, Cambridge, MA 02139, US

Inventor

  • Name:
    BARON, Michelle
  • Address:
    Boston, MA 02210, US
  • Name:
    YOUNG, Andrew
  • Address:
    Boston, MA 02210, US

Priority

  • Number:
    201762441833 P
  • Date:
    3.1.2017
  • Country:
    US

Classification

  • Categories:
    A61K 38/26, A61K 31/37, A61K 31/40, A61K 31/401, A61K 31/565, A61K 31/567, A61K 31/7048, A61P 3/10

Upload documents